Privia Health Group Inc (PRVA) concluded trading on Wednesday at a closing price of $21.66, with 0.45 million shares of worth about $9.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.49% during that period and on November 27, 2024 the price saw a gain of about 0.74%. Currently the company’s common shares owned by public are about 118.22M shares, out of which, 106.24M shares are available for trading.
Stock saw a price change of 4.18% in past 5 days and over the past one month there was a price change of 20.53%. Year-to-date (YTD), PRVA shares are showing a performance of -5.95% which decreased to -1.99% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $15.92 but also hit the highest price of $24.30 during that period. The average intraday trading volume for Privia Health Group Inc shares is 784.34K. The stock is currently trading 2.63% above its 20-day simple moving average (SMA20), while that difference is up 13.18% for SMA50 and it goes to 14.18% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Privia Health Group Inc (NASDAQ: PRVA) currently have 118.22M outstanding shares and institutions hold larger chunk of about 97.08% of that.
The stock has a current market capitalization of $2.60B and its 3Y-monthly beta is at 0.83. PE ratio of stock for trailing 12 months is 211.52, while it has posted earnings per share of $0.10 in the same period. Its PEG reads 8.14 and has Quick Ratio of 1.78 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PRVA, volatility over the week remained 3.61% while standing at 4.53% over the month.
Stock’s fiscal year EPS is expected to drop by -29.53% while it is estimated to increase by 92.59% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by KeyBanc Capital Markets on October 11, 2024 offering an Overweight rating for the stock and assigned a target price of $23 to it. Coverage by Robert W. Baird stated Privia Health Group Inc (PRVA) stock as an Outperform in their note to investors on May 30, 2024, suggesting a price target of $23 for the stock. On April 22, 2024, Citigroup Initiated their recommendations, while on March 06, 2024, Barclays Initiated their ratings for the stock with a price target of $22. Stock get a Buy rating from Jefferies on February 26, 2024.
